Items
Creator is exactly
Jing-Xin Li
-
2020-05-22Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
The new process of coronavirus vaccine in China